Humankind Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,959
Closed -$3.78M 106
2025
Q3
$3.78M Buy
4,959
+574
+13% +$427K 0.87% 18
2025
Q2
$3.42M Buy
4,385
+605
+16% +$470K 0.83% 18
2025
Q1
$3.12M Sell
3,780
-588
-13% -$489K 0.81% 18
2024
Q4
$3.37M Buy
4,368
+985
+29% +$816K 0.85% 18
2024
Q3
$3M Sell
3,383
-464
-12% -$417K 1.08% 13
2024
Q2
$3.48M Sell
3,847
-68
-2% -$54.4K 0.92% 17
2024
Q1
$3.05M Sell
3,915
-867
-18% -$617K 0.81% 21
2023
Q4
$2.79M Sell
4,782
-459
-9% -$268K 0.83% 19
2023
Q3
$2.82M Sell
5,241
-1,252
-19% -$645K 1.17% 11
2023
Q2
$3.05M Buy
6,493
+896
+16% +$376K 1.19% 12
2023
Q1
$1.92M Buy
5,597
+543
+11% +$183K 0.8% 20
2022
Q4
$1.85M Sell
5,054
-621
-11% -$220K 0.8% 19
2022
Q3
$1.83M Buy
5,675
+801
+16% +$254K 0.88% 20
2022
Q2
$1.58M Sell
4,874
-153
-3% -$45.9K 0.76% 21
2022
Q1
$1.44M Buy
5,027
+596
+13% +$153K 0.59% 26
2021
Q4
$1.22M Buy
4,431
+564
+15% +$143K 1.54% 16
2021
Q3
$893K Sell
3,867
-148
-4% -$36.5K 1.36% 19
2021
Q2
$922K Buy
4,015
+1,745
+77% +$351K 1.64% 18
2021
Q1
$424K Buy
+2,270
New +$444K 1.3% 28

Other funds holding LLY

Humankind Investments's LLY Position: Q4 2025 in Review

Humankind Investments sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 4,959 shares — an estimated $3.78M sold.

Humankind Investments first reported a position in LLY in Q1 2021 and held it in 19 quarters. The position peaked at $3.78M in Q3 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Humankind Investments reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 4,959 Eli Lilly shares in Q4 2025, an estimated $3.78M.
  • Humankind Investments first reported a position in Eli Lilly in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's Eli Lilly position peaked at $3.78M in Q3 2025.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.